
Delia M. Ramirez
Examiner (ID: 4462)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1518 |
| Issued Applications | 818 |
| Pending Applications | 200 |
| Abandoned Applications | 534 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18199656
[patent_doc_number] => 20230053176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR RECOGNITION SEQUENCES IN THE DYSTROPHIN GENE
[patent_app_type] => utility
[patent_app_number] => 17/931896
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931896
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931896 | Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene | Sep 12, 2022 | Issued |
Array
(
[id] => 19977407
[patent_doc_number] => 12344870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => Compositions comprising a CRISPR nuclease and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/930595
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 49777
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930595 | Compositions comprising a CRISPR nuclease and uses thereof | Sep 7, 2022 | Issued |
Array
(
[id] => 19977407
[patent_doc_number] => 12344870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => Compositions comprising a CRISPR nuclease and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/930595
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 49777
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930595 | Compositions comprising a CRISPR nuclease and uses thereof | Sep 7, 2022 | Issued |
Array
(
[id] => 18109867
[patent_doc_number] => 20230002747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => DNA MODIFYING ENZYMES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/929162
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929162 | DNA modifying enzymes and active fragments and variants thereof and methods of use | Aug 31, 2022 | Issued |
Array
(
[id] => 19258261
[patent_doc_number] => 12018307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Process for producing a glucuronide and genetically modified microorganisms useful in this process
[patent_app_type] => utility
[patent_app_number] => 17/822733
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 34
[patent_no_of_words] => 16928
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822733 | Process for producing a glucuronide and genetically modified microorganisms useful in this process | Aug 25, 2022 | Issued |
Array
(
[id] => 18452045
[patent_doc_number] => 20230193324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => CRISPR HYBRID DNA/RNA POLYNUCLEOTIDES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/888027
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24878
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/888027 | CRISPR HYBRID DNA/RNA POLYNUCLEOTIDES AND METHODS OF USE | Aug 14, 2022 | Pending |
Array
(
[id] => 18452045
[patent_doc_number] => 20230193324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => CRISPR HYBRID DNA/RNA POLYNUCLEOTIDES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/888027
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24878
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/888027 | CRISPR HYBRID DNA/RNA POLYNUCLEOTIDES AND METHODS OF USE | Aug 14, 2022 | Pending |
Array
(
[id] => 18469255
[patent_doc_number] => 20230203539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING STATHMIN 2 (STMN2) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/885876
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17885876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/885876 | GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING STATHMIN 2 (STMN2) AND USES THEREOF | Aug 10, 2022 | Abandoned |
Array
(
[id] => 18212476
[patent_doc_number] => 20230058740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => Robust Protein Expression Enabled by Dynamic Control over Host Proteases
[patent_app_type] => utility
[patent_app_number] => 17/819100
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819100 | Robust Protein Expression Enabled by Dynamic Control over Host Proteases | Aug 10, 2022 | Pending |
Array
(
[id] => 18338909
[patent_doc_number] => 20230130858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => TARGET-SPECIFIC CRISPR MUTANT
[patent_app_type] => utility
[patent_app_number] => 17/880160
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17880160
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/880160 | TARGET-SPECIFIC CRISPR MUTANT | Aug 2, 2022 | Pending |
Array
(
[id] => 18338909
[patent_doc_number] => 20230130858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => TARGET-SPECIFIC CRISPR MUTANT
[patent_app_type] => utility
[patent_app_number] => 17/880160
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17880160
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/880160 | TARGET-SPECIFIC CRISPR MUTANT | Aug 2, 2022 | Pending |
Array
(
[id] => 18469122
[patent_doc_number] => 20230203406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => AUTOMATIC DISHWASHING DETERGENT COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/879030
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879030
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/879030 | AUTOMATIC DISHWASHING DETERGENT COMPOSITION | Aug 1, 2022 | Abandoned |
Array
(
[id] => 18212877
[patent_doc_number] => 20230059141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => GENE EDITING SYSTEMS COMPRISING A NUCLEASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/815846
[patent_app_country] => US
[patent_app_date] => 2022-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815846
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815846 | GENE EDITING SYSTEMS COMPRISING A NUCLEASE AND USES THEREOF | Jul 27, 2022 | Pending |
Array
(
[id] => 20316140
[patent_doc_number] => 12454684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Methods using novel CPF1 mutations that enhance the DNA cleavage activity of
[patent_app_type] => utility
[patent_app_number] => 17/873485
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 40687
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873485
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/873485 | Methods using novel CPF1 mutations that enhance the DNA cleavage activity of | Jul 25, 2022 | Issued |
Array
(
[id] => 20316140
[patent_doc_number] => 12454684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Methods using novel CPF1 mutations that enhance the DNA cleavage activity of
[patent_app_type] => utility
[patent_app_number] => 17/873485
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 40687
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873485
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/873485 | Methods using novel CPF1 mutations that enhance the DNA cleavage activity of | Jul 25, 2022 | Issued |
Array
(
[id] => 18005367
[patent_doc_number] => 20220364133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => Carbohydrate Binding Module Variants And Polynucleotides Encoding Same
[patent_app_type] => utility
[patent_app_number] => 17/812259
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812259
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812259 | Carbohydrate Binding Module Variants And Polynucleotides Encoding Same | Jul 12, 2022 | Pending |
Array
(
[id] => 20372681
[patent_doc_number] => 12480107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Lipase variants and the use thereof
[patent_app_type] => utility
[patent_app_number] => 17/716624
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61545
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716624
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716624 | Lipase variants and the use thereof | Jul 5, 2022 | Issued |
Array
(
[id] => 20187277
[patent_doc_number] => 12398384
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => DNA modifying enzymes and active fragments and variants thereof and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/851880
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58200
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851880
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851880 | DNA modifying enzymes and active fragments and variants thereof and methods of use | Jun 27, 2022 | Issued |
Array
(
[id] => 17946073
[patent_doc_number] => 20220333090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => MODIFIED CAS9 PROTEIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/849581
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17849581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/849581 | Polynucleotide encoding modified CAS9 protein | Jun 23, 2022 | Issued |
Array
(
[id] => 18212201
[patent_doc_number] => 20230058465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => Compositions And Methods For Production Of Salidroside, Icariside D2, And Precursors Of Salidroside And Icariside D2
[patent_app_type] => utility
[patent_app_number] => 17/847313
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17847313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/847313 | Compositions and methods for production of salidroside, icariside D2, and precursors of salidroside and icariside D2 | Jun 22, 2022 | Issued |